Izotropic Financial Statements From 2010 to 2025
| IZOZF Stock | USD 0.21 0.01 4.55% |
Check Izotropic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Izotropic's main balance sheet or income statement drivers, such as , as well as many indicators such as . Izotropic financial statements analysis is a perfect complement when working with Izotropic Valuation or Volatility modules.
Izotropic |
Izotropic OTC Stock Current Valuation Analysis
Izotropic's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Izotropic Current Valuation | 26.87 M |
Most of Izotropic's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Izotropic is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Izotropic has a Current Valuation of 26.87 M. This is 99.81% lower than that of the Healthcare sector and 99.66% lower than that of the Diagnostics & Research industry. The current valuation for all United States stocks is 99.84% higher than that of the company.
Izotropic Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Izotropic's current stock value. Our valuation model uses many indicators to compare Izotropic value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Izotropic competition to find correlations between indicators driving Izotropic's intrinsic value. More Info.Izotropic is currently regarded as number one stock in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Izotropic's earnings, one of the primary drivers of an investment's value.About Izotropic Financial Statements
Izotropic stakeholders use historical fundamental indicators, such as Izotropic's revenue or net income, to determine how well the company is positioned to perform in the future. Although Izotropic investors may analyze each financial statement separately, they are all interrelated. For example, changes in Izotropic's assets and liabilities are reflected in the revenues and expenses on Izotropic's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Izotropic. Please read more on our technical analysis and fundamental analysis pages.
Izotropic Corporation, a MedTech company, commercializes diagnostic products for breast cancer. The company was incorporated in 2016 and is headquartered in Surrey, Canada. Izotropic Corp operates under Diagnostics Research classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Izotropic OTC Stock
Izotropic financial ratios help investors to determine whether Izotropic OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Izotropic with respect to the benefits of owning Izotropic security.